A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
Conditions
- Sickle Cell Disease
- Thalassemia
- Hemoglobinopathies
Interventions
- OTHER: Busulfan; Fludarabine; cyclosporine A and MMF
Sponsor
University of Pittsburgh